A detailed history of New York State Teachers Retirement System transactions in Biogen Inc. stock. As of the latest transaction made, New York State Teachers Retirement System holds 117,801 shares of BIIB stock, worth $18.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
117,801
Previous 123,335 4.49%
Holding current value
$18.8 Million
Previous $28.6 Million 20.14%
% of portfolio
0.05%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$189.07 - $236.8 $1.05 Million - $1.31 Million
-5,534 Reduced 4.49%
117,801 $22.8 Million
Q2 2024

Jul 24, 2024

SELL
$190.52 - $236.72 $663,771 - $824,732
-3,484 Reduced 2.75%
123,335 $28.6 Million
Q1 2024

Apr 25, 2024

SELL
$212.02 - $267.71 $1.83 Million - $2.31 Million
-8,630 Reduced 6.37%
126,819 $27.3 Million
Q4 2023

Jan 24, 2024

SELL
$222.59 - $267.94 $1.69 Million - $2.04 Million
-7,609 Reduced 5.32%
135,449 $35.1 Million
Q3 2023

Oct 25, 2023

SELL
$253.3 - $285.89 $2.82 Million - $3.18 Million
-11,131 Reduced 7.22%
143,058 $36.8 Million
Q2 2023

Jul 27, 2023

SELL
$275.25 - $318.06 $2.18 Million - $2.51 Million
-7,902 Reduced 4.88%
154,189 $43.9 Million
Q1 2023

Apr 27, 2023

SELL
$256.56 - $292.34 $412,291 - $469,790
-1,607 Reduced 0.98%
162,091 $45.1 Million
Q4 2022

Jan 27, 2023

BUY
$252.44 - $306.72 $202,204 - $245,682
801 Added 0.49%
163,698 $45.3 Million
Q3 2022

Oct 28, 2022

BUY
$194.69 - $268.46 $405,928 - $559,739
2,085 Added 1.3%
162,897 $43.5 Million
Q2 2022

Aug 01, 2022

SELL
$187.54 - $223.02 $749,222 - $890,964
-3,995 Reduced 2.42%
160,812 $32.8 Million
Q1 2022

Apr 27, 2022

SELL
$193.77 - $244.14 $2.19 Million - $2.76 Million
-11,306 Reduced 6.42%
164,807 $34.7 Million
Q4 2021

Jan 24, 2022

SELL
$223.92 - $287.77 $1.57 Million - $2.02 Million
-7,010 Reduced 3.83%
176,113 $42.3 Million
Q3 2021

Oct 25, 2021

SELL
$282.99 - $369.05 $1.78 Million - $2.32 Million
-6,285 Reduced 3.32%
183,123 $51.8 Million
Q2 2021

Jul 21, 2021

SELL
$259.0 - $414.71 $3.01 Million - $4.82 Million
-11,632 Reduced 5.79%
189,408 $65.6 Million
Q1 2021

Apr 22, 2021

SELL
$242.95 - $284.63 $7.3 Million - $8.55 Million
-30,041 Reduced 13.0%
201,040 $56.2 Million
Q4 2020

Jan 25, 2021

SELL
$236.26 - $355.63 $4.18 Million - $6.29 Million
-17,683 Reduced 7.11%
231,081 $56.6 Million
Q3 2020

Nov 06, 2020

SELL
$264.77 - $305.71 $5.26 Million - $6.07 Million
-19,871 Reduced 7.4%
248,764 $0
Q2 2020

Jul 21, 2020

SELL
$258.66 - $342.55 $6.28 Million - $8.32 Million
-24,294 Reduced 8.29%
268,635 $71.9 Million
Q1 2020

Apr 29, 2020

SELL
$268.85 - $341.04 $3.23 Million - $4.09 Million
-12,000 Reduced 3.94%
292,929 $92.7 Million
Q4 2019

Jan 24, 2020

SELL
$220.06 - $304.07 $1.52 Million - $2.1 Million
-6,900 Reduced 2.21%
304,929 $90.5 Million
Q3 2019

Oct 24, 2019

SELL
$217.44 - $243.88 $180,257 - $202,176
-829 Reduced 0.27%
311,829 $72.6 Million
Q2 2019

Jul 18, 2019

SELL
$219.29 - $241.72 $3.96 Million - $4.36 Million
-18,057 Reduced 5.46%
312,658 $73.1 Million
Q1 2019

May 07, 2019

BUY
$216.71 - $338.96 $265,903 - $415,903
1,227 Added 0.37%
330,715 $78.2 Million
Q4 2018

Jan 28, 2019

SELL
$278.5 - $352.75 $4.76 Million - $6.03 Million
-17,093 Reduced 4.93%
329,488 $99.2 Million
Q3 2018

Nov 02, 2018

SELL
$293.51 - $383.83 $3.48 Million - $4.55 Million
-11,850 Reduced 3.31%
346,581 $122 Million
Q2 2018

Aug 01, 2018

SELL
$257.52 - $306.91 $2.66 Million - $3.16 Million
-10,310 Reduced 2.8%
358,431 $104 Million
Q1 2018

May 01, 2018

SELL
$260.13 - $367.91 $1.24 Million - $1.76 Million
-4,779 Reduced 1.28%
368,741 $101 Million
Q4 2017

Feb 12, 2018

SELL
$307.64 - $344.58 $892,156 - $999,282
-2,900 Reduced 0.77%
373,520 $119 Million
Q3 2017

Oct 30, 2017

SELL
$281.15 - $329.69 $2.24 Million - $2.62 Million
-7,954 Reduced 2.07%
376,420 $118 Million
Q2 2017

Aug 11, 2017

BUY
N/A
384,374
384,374 $104 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.